Our reference on how TB-500 affects cytoskeletal regulation and stem-cell migration walks through that mechanism, and what research says about TB-500 for tissue repair surveys the outcomes literature
1 mL VIAL, 10 mL MULTIPLE DOSE VIAL, 30 mL MULTIPLE DOSE VIAL For Intramuscular or Subcutaneous Use Only Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit
TB-500 : 43-amino-acid analog of thymosin 4, examined for actin binding/sequestration, cell motility, microtubule/cytoskeleton remodeling, and re-epithelialization in injury models
Animal models of myocardial infarction show that TB-500 administration improves left ventricular function, reduces infarct size and cardiomyocyte death during ischemic events, and enhances cardiac microvascular density to improve tissue perfusion
Severe hypoglycemia and coronary artery calcification during the diabetes control and complications trial/epidemiology of diabetes interventions and complications (DCCT/EDIC) study
